2022 Global Report of Heated Tobacco Products

Industry Insight by Alice Wang
Jun.15.2023
2022 Global Report of Heated Tobacco Products
The Eastern Tobacco Daily reports on global tobacco sales of heated products, with Japan, Italy, and Russia leading the way.

Recently, the Eastern Tobacco News released an article titled "Report on the Development of World Tobacco Industry in 2022 (Part One)", written by the Policy Research Office of the National Economic Research Institute.

 

According to the article, in 2022, the sales of heated tobacco products reached $33.38 billion, a 15.8% increase compared to the previous year. Out of this, 30 million units of heated tobacco devices were sold, generating $2.09 billion in revenue, while sales of heated tobacco sticks reached 2.756 million boxes, generating $31.28 billion in revenue.

 

According to market analysis, Japan, Italy, and Russia rank as the top three countries in the world for sales, with revenue of $12.77 billion, $4.11 billion, and $2.54 billion, respectively. Japan's growth in heated tobacco products has been slowing, and its share of global sales has been decreasing from over 80% before 2017 to 38.3% in 2022.

 

When looking at the industry as a whole, Philip Morris International (PMI) maintains a dominant position, followed closely by British American Tobacco and Japan Tobacco. These three companies collectively make up 71.4%, 15.5%, and 4.3% of the global heated tobacco market share, respectively.

 

Reference material:

 

The World Tobacco Development Report (Part I) for 2022

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.